AWM
FLGT icon

Apollon Wealth Management’s Fulgent Genetics FLGT Stock Holding History

Apollon Wealth Management’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-7,310
Closed -$279K – 872
2022
Q3 		$279K Buy
7,310
+2,915
+66% +$146K 0.02% 628
2022
Q2 		$240K Buy
4,395
+63
+1% +$3.46K 0.02% 630
2022
Q1 		$270K Sell
4,332
-660
-13% -$43.5K 0.02% 611
2021
Q4 		$502K Sell
4,992
-58
-1% -$5.1K 0.04% 464
2021
Q3 		$454K Buy
5,050
+738
+17% +$67.1K 0.06% 288
2021
Q2 		$398K Buy
4,312
+617
+17% +$49.3K 0.07% 244
2021
Q1 		$357K Buy
+3,695
New +$381K 0.07% 246

Other funds holding FLGT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Apollon Wealth Management's FLGT Position: Q4 2022 in Review

Apollon Wealth Management sold out of Fulgent Genetics (FLGT) in Q4 2022, closing a stake of 7,310 shares — an estimated $279K sold.

Apollon Wealth Management first reported a position in FLGT in Q1 2021 and held it in 7 quarters. The position peaked at $502K in Q4 2021. 224 funds tracked by Wall St. Rank hold FLGT as of Q4 2022.

  • Apollon Wealth Management reported no remaining Fulgent Genetics position as of Q4 2022 after selling out during the quarter.
  • Apollon Wealth Management sold 7,310 Fulgent Genetics shares in Q4 2022, an estimated $279K.
  • Apollon Wealth Management first reported a position in Fulgent Genetics in Q1 2021 and held it in 7 quarters.
  • Apollon Wealth Management's Fulgent Genetics position peaked at $502K in Q4 2021.
  • 224 funds tracked by Wall St. Rank held Fulgent Genetics as of Q4 2022.

Based on Apollon Wealth Management's 13F filing for Q4 2022, filed 15 Feb 2023.